See us at EANM 2017 in Vienna, Austria – Booth 226
Seeing more matters in Molecular Imaging Learn more about MILabs’ multi-modality preclinical imaging platforms, with PET/SPECT/OI/CT platforms at <0.14 mm SPECT resolution and <0.6 mm PET resolution.
The systems feature hybrid nuclear and optical imaging, with unmatched morphological 4D CT capabilities.
Multimodal Molecular Imaging
MILabs’ multimodal molecular imaging platforms can help take your research to the next level. Stop by our booth 226 at EANM 2017 to learn more about our SPECT, PET, CT and Optical systems and how we can help you!
Clinical SPECT: G-SPECT
No one will see it like you
Stunning SPECT Image Details:
Ten-fold image resolution improvement over current state-of-the-art SPECT systems
Extra Insight with Dynamic SPECT:
Now, you can you visualize dynamic processes to improve diagnostic accuracy
See More with Less:
With G-SPECT, you can see sharper while cutting tracer dose up to ten-fold.
G-SPECT equipment is being developed for human use. Clinical availability depends on final local (pre)market approval, including FDA and CE approval. Shown equipment is not yet for sale as a clinical device.
MILabs products are used in more than 65 countries and are supported by a global network of distributors and factory trained support engineers.
Please contact MILabs directly for more information about your local MILabs business partner.